Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 156
9
Diseases
29
Unique genes
0.473
Avg. similarity score
Congenital afibrinogenemia
Most-connected disease (8 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Congenital afibrinogenemia
Afibrinogenemia
Congenital fibrinogen deficiency
Congenital hypofibrinogenemia
Dysfibrinogenemia
Hypofibrinogenemia
Thromboembolic pulmonary hypertension
Deep vein thrombosis
Cor pulmonale
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congenital afibrinogenemia | 8 | 8 | 3 |
| Afibrinogenemia | 7 | 7 | 3 |
| Congenital fibrinogen deficiency | 7 | 7 | 3 |
| Congenital hypofibrinogenemia | 7 | 7 | 3 |
| Dysfibrinogenemia | 5 | 5 | 5 |
| Hypofibrinogenemia | 5 | 5 | 3 |
| Thromboembolic pulmonary hypertension | 5 | 5 | 9 |
| Deep vein thrombosis | 4 | 4 | 10 |
| Cor pulmonale | 2 | 2 | 15 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| FGA | 9 / 9 | Afibrinogenemia, Congenital afibrinogenemia, Congenital fibrinogen deficiency, Congenital hypofibrinogenemia and 5 more |
| FGG | 8 / 9 | Afibrinogenemia, Congenital afibrinogenemia, Congenital fibrinogen deficiency, Congenital hypofibrinogenemia and 4 more |
| FGB | 7 / 9 | Afibrinogenemia, Congenital afibrinogenemia, Congenital fibrinogen deficiency, Congenital hypofibrinogenemia and 3 more |
| ABO | 2 / 9 | Cor pulmonale, Thromboembolic pulmonary hypertension |
| F11 | 2 / 9 | Cor pulmonale, Thromboembolic pulmonary hypertension |
| SLC44A2 | 2 / 9 | Cor pulmonale, Thromboembolic pulmonary hypertension |
| TSPAN15 | 2 / 9 | Cor pulmonale, Thromboembolic pulmonary hypertension |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Common Pathway of Fibrin Clot Formation | Reactome | 10 / 22 | 188× | 7.43e-22 | 8.12e-19 ✓ sig. |
| Complement and coagulation cascades | KEGG | 13 / 88 | 61.2× | 4.30e-21 | 4.20e-18 ✓ sig. |
| Intrinsic Pathway of Fibrin Clot Formation | Reactome | 6 / 23 | 108× | 1.12e-11 | 1.98e-9 ✓ sig. |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | Reactome | 8 / 125 | 26.5× | 3.93e-10 | 4.89e-8 ✓ sig. |
| Post-translational protein phosphorylation | Reactome | 6 / 108 | 23.0× | 1.85e-7 | 1.12e-5 ✓ sig. |
| Platelet degranulation | Reactome | 6 / 123 | 20.2× | 4.00e-7 | 2.21e-5 ✓ sig. |
| Gamma-carboxylation of protein precursors | Reactome | 3 / 9 | 138× | 1.05e-6 | 5.11e-5 ✓ sig. |
| Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | Reactome | 3 / 9 | 138× | 1.05e-6 | 5.11e-5 ✓ sig. |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | Reactome | 3 / 10 | 124× | 1.50e-6 | 6.93e-5 ✓ sig. |
| p130Cas linkage to MAPK signaling for integrins | Reactome | 3 / 15 | 82.8× | 5.65e-6 | 2.10e-4 ✓ sig. |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | Reactome | 3 / 15 | 82.8× | 5.65e-6 | 2.10e-4 ✓ sig. |
| Platelet activation | KEGG | 5 / 126 | 16.4× | 1.14e-5 | 3.73e-4 ✓ sig. |
| Regulation of TLR by endogenous ligand | Reactome | 3 / 19 | 65.4× | 1.20e-5 | 3.89e-4 ✓ sig. |
| Integrin signaling | Reactome | 3 / 23 | 54.0× | 2.17e-5 | 6.39e-4 ✓ sig. |
| Cell surface interactions at the vascular wall | Reactome | 4 / 84 | 19.7× | 4.63e-5 | 1.20e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| hemostasis | GO:0007599 | 12 / 55 | 141× | 5.82e-24 | 1.63e-20 ✓ sig. |
| blood coagulation | GO:0007596 | 13 / 106 | 79.0× | 1.85e-22 | 4.29e-19 ✓ sig. |
| fibrinolysis | GO:0042730 | 7 / 19 | 237× | 4.93e-16 | 4.09e-13 ✓ sig. |
| plasminogen activation | GO:0031639 | 5 / 12 | 268× | 4.92e-12 | 1.93e-9 ✓ sig. |
| platelet activation | GO:0030168 | 7 / 69 | 65.4× | 1.00e-11 | 3.69e-9 ✓ sig. |
| blood coagulation, fibrin clot formation | GO:0072378 | 3 / 9 | 215× | 2.80e-7 | 2.88e-5 ✓ sig. |
| positive regulation of peptide hormone secretion | GO:0090277 | 3 / 10 | 193× | 4.00e-7 | 3.87e-5 ✓ sig. |
| regulation of blood coagulation | GO:0030193 | 3 / 11 | 176× | 5.50e-7 | 5.07e-5 ✓ sig. |
| negative regulation of fibrinolysis | GO:0051918 | 3 / 12 | 161× | 7.32e-7 | 6.45e-5 ✓ sig. |
| positive regulation of heterotypic cell-cell adhesion | GO:0034116 | 3 / 13 | 149× | 9.51e-7 | 7.98e-5 ✓ sig. |
| protein polymerization | GO:0051258 | 3 / 17 | 114× | 2.25e-6 | 1.58e-4 ✓ sig. |
| trans-synaptic signaling by BDNF, modulating synaptic transmission | GO:0099183 | 2 / 3 | 430× | 6.97e-6 | 3.91e-4 ✓ sig. |
| positive regulation of exocytosis | GO:0045921 | 3 / 26 | 74.4× | 8.53e-6 | 4.60e-4 ✓ sig. |
| positive regulation of vasoconstriction | GO:0045907 | 3 / 27 | 71.6× | 9.59e-6 | 5.05e-4 ✓ sig. |
| negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902042 | 3 / 29 | 66.7× | 1.19e-5 | 5.98e-4 ✓ sig. |